Prot#211-00/FOS 530: Rndmzd, Dbl-Blind, Dbl-Dummy, Prll-Grp, Mlticntr Stdy to Eval & Comp Effects of 1x Wkly Alendronate & Risedronate on Bone Mineral Density in Postmenopausal Women w/Osteoporosis (FACT - FOSAMAX® ACTONEL® Comparison Trial)

Project: Research project

Project Details

StatusFinished
Effective start/end date8/23/04 → 12/31/05

Funding

  • NorthShore University HealthSystem Research Institute (211-00/FOS 530)
  • Merck & Co., Inc. (211-00/FOS 530)